372 related articles for article (PubMed ID: 11518073)
1. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
Friede M; Henneicke von Zepelin HH; Freudenstein J
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S38-41. PubMed ID: 11518073
[TBL] [Abstract][Full Text] [Related]
2. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
3. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.
Schrader E
Int Clin Psychopharmacol; 2000 Mar; 15(2):61-8. PubMed ID: 10759336
[TBL] [Abstract][Full Text] [Related]
4. Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine.
Volz HP; Laux P
Compr Psychiatry; 2000; 41(2 Suppl 1):133-7. PubMed ID: 10746915
[TBL] [Abstract][Full Text] [Related]
5. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine.
Harrer G; Schmidt U; Kuhn U; Biller A
Arzneimittelforschung; 1999 Apr; 49(4):289-96. PubMed ID: 10337446
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
8. Current St John's wort research from mode of action to clinical efficacy.
Müller WE
Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
[TBL] [Abstract][Full Text] [Related]
9. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
Röder C; Schaefer M; Leucht S
Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of St John's wort in major depression: a randomized controlled trial.
Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
[TBL] [Abstract][Full Text] [Related]
12. St John's Wort (Hypericum perforatum)--a herbal antidepressant.
Hippius H
Curr Med Res Opin; 1998; 14(3):171-84. PubMed ID: 9787983
[TBL] [Abstract][Full Text] [Related]
13. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
14. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
15. [Use of St. John's Wort for depression in primary care - a non-interventional study].
Musselmann B; Rychlik R; Burkart M
MMW Fortschr Med; 2011 Dec; 153 Suppl 4():119-27. PubMed ID: 23964473
[TBL] [Abstract][Full Text] [Related]
16. About the cover: St. John's wort.
J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
19. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T
Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Solomon D; Adams J; Graves N
J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]